Deep immunophenotyping reveals circulating activated lymphocytes in individuals at risk for rheumatoid arthritis

Rheumatoid arthritis (RA) is a systemic autoimmune disease currently with no universally highly effective prevention strategies. Identifying pathogenic immune phenotypes in at-risk populations prior to clinical onset is crucial to establishing effective prevention strategies. Here, we applied multimodal single-cell technologies (mass cytometry and CITE-Seq) to characterize the immunophenotypes in blood from at-risk individuals (ARIs) identified through the presence of serum antibodies against citrullinated protein antigens (ACPAs) and/or first-degree relative (FDR) status, as compared with patients with established RA and people in a healthy control group. We identified significant cell expansions in ARIs compared with controls, including CCR2+CD4+ T cells, T peripheral helper (Tph) cells, type 1 T helper cells, and CXCR5+CD8+ T cells. We also found that CD15+ classical monocytes were specifically expanded in ACPA-negative FDRs, and an activated PAX5lo naive B cell population was expanded in ACPA-positive FDRs. Further, we uncovered the molecular phenotype of the CCR2+CD4+ T cells, expressing high levels of Th17- and Th22-related signature transcripts including CCR6, IL23R, KLRB1, CD96, and IL22. Our integrated study provides a promising approach to identify targets to improve prevention strategy development for RA.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Investigation
Published
2025-03-16
DOI
https://doi.org/10.1172/jci185217
Citations
22
Primary Topic
Systemic Lupus Erythematosus Research
Type
article
Field-Weighted Citation Impact
36.70

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Deep immunophenotyping reveals circulating activated lymphocytes in individuals at risk for rheumatoid arthritis

Tusharkanti Ghosh, Michael B. Brenner, Kevin D. Deane, Jill M. Norris et al.
22 citations
Journal of Clinical Investigation
Systemic Lupus Erythematosus Research
36.70
article

Deep immunophenotyping reveals circulating activated lymphocytes in individuals at risk for rheumatoid arthritis

Tusharkanti Ghosh, Michael B. Brenner, Kevin D. Deane, Jill M. Norris, Carla M. Cuda, Alec Griffith, Laura T. Donlin, Justin Pulford, Jeffrey A. Sparks, Gary S. Firestein, Jennifer H. Anolik, Susan M. Goodman, Harris Perlman, Joel M. Guthridge, James A. Lederer, V. Michael Holers, Joan M. Bathon, Vivian P. Bykerk, Andrew D. Filer, Nir Hacohen, Miranda G. Gurra, Costantino Pitzalis, Jun Inamo, Alice Horisberger, Brandon L. Hancock, Fan Zhang, Larry W. Moreland, Salina Dominguez, Siddarth Gurajala, Kaitlyn Howard, Anna Helena Jonsson, Soumya Raychaudhuri, Marie L. Feser, Deepak A. Rao, Judith A. James, S. Louis Bridges, Jennifer Seifert, Ekaterina Murzin, Ye Cao, Laura B. Hughes, Joshua Keegan, William Apruzzese
article en
22 citations

Abstract

Rheumatoid arthritis (RA) is a systemic autoimmune disease currently with no universally highly effective prevention strategies. Identifying pathogenic immune phenotypes in at-risk populations prior to clinical onset is crucial to establishing effective prevention strategies. Here, we applied multimodal single-cell technologies (mass cytometry and CITE-Seq) to characterize the immunophenotypes in blood from at-risk individuals (ARIs) identified through the presence of serum antibodies against citrullinated protein antigens (ACPAs) and/or first-degree relative (FDR) status, as compared with patients with established RA and people in a healthy control group. We identified significant cell expansions in ARIs compared with controls, including CCR2+CD4+ T cells, T peripheral helper (Tph) cells, type 1 T helper cells, and CXCR5+CD8+ T cells. We also found that CD15+ classical monocytes were specifically expanded in ACPA-negative FDRs, and an activated PAX5lo naive B cell population was expanded in ACPA-positive FDRs. Further, we uncovered the molecular phenotype of the CCR2+CD4+ T cells, expressing high levels of Th17- and Th22-related signature transcripts including CCR6, IL23R, KLRB1, CD96, and IL22. Our integrated study provides a promising approach to identify targets to improve prevention strategy development for RA.

Journal of Clinical InvestigationVol. 135(6)
Broad Institute (US), Northwestern University (US), Hospital for Special Surgery (US), Brigham and Women's Hospital (US), La Jolla Institute for Immunology (US), Humanitas University (IT), Harvard University (US), Colorado School of Public Health (US), Queen Mary University of London (GB), Cornell University (US), University of Rochester Medical Center (US), Oklahoma Medical Research Foundation (US), University of Alabama at Birmingham (US), Arthritis Society (CA), Northwestern Medicine (US), William Harvey Research Institute (GB), Center for Rheumatology (US), NIHR Birmingham Biomedical Research Centre (GB), Columbia University (US), University of Birmingham (GB), University of Colorado Denver (US), University of Lausanne (CH)
National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zero hunger
Openalex Percentile: Top 0%
Systemic Lupus Erythematosus Research
36.70
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.